Literature DB >> 6288202

Sulphide as an inhibitor and electron donor for the cytochrome c oxidase system.

P Nicholls, J K Kim.   

Abstract

Anomalies both kinetic and equilibrium in nature are described for the inhibition of cytochrome c oxidase activity by sulphide in the isolated enzyme and in submitochondrial particles. These anomalies are related to the involvement of more than 1 mol of sulphide in the blockage of one cytochrome aa3 centre. Sulphide reduces resting cytochrome a3, a reaction that results in oxygen uptake and the loss of a sulphide molecule. Sulphide can also reduce cytochromes c and a; in the former case, a part of the one-equivalent oxidation product, presumed to be the SH radical, reacts with oxygen. Such oxygen uptake is also seen under aerobic conditions when ferricyanide reacts with sulphide. Three phases are identified in the inhibitory interaction of sulphide with the cytochrome c oxidase enzyme itself: an initial rapid reaction involving sulphide oxidation, oxygen uptake, and conversion of cytochrome aa3 into the low-spin "oxyferri" form; a subsequent step in which sulphide reduces cytochrome a; and the final inhibitory step in which a third molecule of sulphide binds the a3 iron centre in the cytochrome a2+ a3 3+ (oxy) species to give cytochrome a2+ a3 3+ H2S. the initial events parallel some of the events in the interaction of the cytochrome c-cytochrome aa3 system with monothiols; the final inhibitory event resembles that with cyanide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288202     DOI: 10.1139/o82-076

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  65 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms.

Authors:  Csaba Szabo; Céline Ransy; Katalin Módis; Mireille Andriamihaja; Baptiste Murghes; Ciro Coletta; Gabor Olah; Kazunori Yanagi; Frédéric Bouillaud
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Inhibition of the phosphate-stimulated cytochrome c oxidase activity by thiophosphate.

Authors:  S Manon; N Camougrand; M Guerin
Journal:  J Bioenerg Biomembr       Date:  1989-06       Impact factor: 2.945

3.  Development of hydrogen sulfide-based therapeutics for cardiovascular disease.

Authors:  Benjamin L Predmore; David J Lefer
Journal:  J Cardiovasc Transl Res       Date:  2010-07-14       Impact factor: 4.132

4.  Redox biochemistry of hydrogen sulfide.

Authors:  Omer Kabil; Ruma Banerjee
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

Review 5.  Hydrogen sulfide and hemeproteins: knowledge and mysteries.

Authors:  Ruth Pietri; Elddie Román-Morales; Juan López-Garriga
Journal:  Antioxid Redox Signal       Date:  2011-04-08       Impact factor: 8.401

6.  H2S oxidation by nanodisc-embedded human sulfide quinone oxidoreductase.

Authors:  Aaron P Landry; David P Ballou; Ruma Banerjee
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

Review 7.  Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.

Authors:  David J Polhemus; David J Lefer
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

8.  Using a functional enzyme model to understand the chemistry behind hydrogen sulfide induced hibernation.

Authors:  James P Collman; Somdatta Ghosh; Abhishek Dey; Richard A Decréau
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

Review 9.  Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide.

Authors:  Daniele Mancardi; Claudia Penna; Annalisa Merlino; Piero Del Soldato; David A Wink; Pasquale Pagliaro
Journal:  Biochim Biophys Acta       Date:  2009-03-13

Review 10.  Chemical Biology of H2S Signaling through Persulfidation.

Authors:  Milos R Filipovic; Jasmina Zivanovic; Beatriz Alvarez; Ruma Banerjee
Journal:  Chem Rev       Date:  2017-11-07       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.